Pharmaceutical commercialization and market access professional serves as a pharmaceuticals expert witness with more than 25 years of experience involving biologic and pharmaceutical product commercialization, pricing strategy, reimbursement frameworks, and global market access. Their work addresses the commercial evaluation and launch planning of specialty therapies across multiple therapeutic areas, including rare diseases, neurology, oncology, neuroscience, and kidney disorders. For more than 10 years, this expert has provided pharmaceuticals expert witness services including consultation, deposition testimony, and courtroom testimony related to pharmaceutical commercialization practices, pricing and reimbursement strategies, and market access considerations affecting specialty drug products.

Key areas of expertise involve global pricing and reimbursement strategy, payer access planning, and market access positioning for biologic and pharmaceutical products across international markets. The expert’s work also includes risk assessment, business analysis, and commercial strategy development supporting drug development programs, product launches, and lifecycle management activities. Additional experience includes evaluation of in-licensing opportunities and pharmaceutical acquisitions, along with commercial planning for specialty therapies navigating complex regulatory submissions, reimbursement environments, and payer policy considerations.

Leadership roles include serving as a cofounder and partner of a consultancy focused on global pharmaceutical and biologic commercial development, as well as cofounder and chief executive of a life sciences consulting alliance providing strategic analysis and commercial insights for life science organizations. The expert also founded a pharmaceutical advisory practice focused on pricing, reimbursement, and market access strategy. Earlier career leadership positions included senior director and brand director roles responsible for global pricing, market access, marketing strategy, and therapeutic area business planning within a multinational pharmaceutical organization. Educational preparation includes a Bachelor of Science in Biological Science and executive education certificates in management and executive leadership coaching. Professional advisory service includes participation on the advisory board of a digital health platform addressing patient medication engagement and pharmaceutical brand support.